{"product_id":"fujifilm-bcg-matrix","title":"Fujifilm Holdings Boston Consulting Group Matrix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDownload Your Competitive Advantage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eFujifilm’s BCG Matrix preview shows a company juggling imaging Stars, healthcare Question Marks, and steady Cash Cows—each with different capital needs and growth paths. Curious which divisions are pulling their weight and which might be ripe for reinvention? Dive deeper: purchase the full BCG Matrix for quadrant-by-quadrant placements, data-backed recommendations, and a ready-to-use Word report plus an Excel summary to present and act on immediately. Get the clarity you need to reallocate capital and shape strategy fast.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etars\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiopharma CDMO (Fujifilm Diosynth Biotechnologies)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn 2024 the global biologics and gene-therapy CDMO market is expanding at a double-digit CAGR and Fujifilm Diosynth Biotechnologies is a top-tier player actively expanding capacity with new sites and advanced tech.\u003c\/p\u003e\n\u003cp\u003eThe business soaks up cash for builds and specialized equipment while a robust pipeline of biologics and gene therapies keeps utilization high.\u003c\/p\u003e\n\u003cp\u003eMaintain investment to defend share and ride secular growth; as the segment matures it is positioned to become an outsized cash engine for Fujifilm.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEndoscopy \u0026amp; minimally invasive medical devices\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eGlobal endoscopy procedure volumes rose about 5% year‑on‑year into 2024, and Fujifilm’s endoscopic imaging and minimally invasive platforms are competitive in hospital purchasing, giving it strong market share in APAC and parts of EMEA. Product upgrades drive repeat capital and consumable spend, supporting recurring revenue. Fujifilm needs more field salesforce muscle and stronger prospective clinical evidence; incremental commercial and R\u0026amp;D spend in 2024 is justified to lock leadership as the market scales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDiagnostic imaging systems + healthcare IT (PACS\/VNA)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHealthcare digitization remains on a growth trajectory in 2024, and Fujifilm's diagnostic imaging plus PACS\/VNA platform is entrenched across major hospital systems. Combined hardware and informatics create sticky, high-share accounts requiring continuous R\u0026amp;D and implementation resources. Management should keep funding to convert installed-base momentum into long-term dominance.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSemiconductor materials for advanced nodes (incl. EUV)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eChips keep getting more complex, driving advanced-node demand for EUV resists and CMP chemistries where Fujifilm holds meaningful positions across resists, CMP and related process chemistries.\u003c\/p\u003e\n\u003cp\u003eHeavy capex and multi-year qualification cycles (TSMC 2024 capex guidance USD 32–36bn) mean near-term cash-in roughly matches cash-out for suppliers; long-term payoff compounds as nodes shrink to 3nm and beyond.\u003c\/p\u003e\n\u003cp\u003eLeadership in these materials creates high barriers and recurring revenue tied to tool and wafer ramps, supporting sustained strategic value.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eresists: EUV specialization\u003c\/li\u003e\n\u003cli\u003eCMP \u0026amp; chemistries: process-critical\u003c\/li\u003e\n\u003cli\u003eTSMC capex 2024: USD 32–36bn\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnterprise data tape (LTO) for hyperscale archiving\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eExploding data volumes and AI training workloads are reviving cold storage demand; IDC projects the global datasphere will approach 175 zettabytes by 2025, driving hyperscale archiving. Fujifilm is a recognized leader in LTO media with broad manufacturing scale and channel credibility; LTO-9 offers 18 TB native per cartridge, easing unit costs. Expansions and format migrations require capex but support a defensible share; when growth normalizes this becomes a durable earner.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMarket driver: IDC 175 ZB by 2025\u003c\/li\u003e\n\u003cli\u003eTech: LTO-9 18 TB native\u003c\/li\u003e\n\u003cli\u003ePositioning: Fujifilm large-scale LTO supplier\u003c\/li\u003e\n\u003cli\u003eRisk: capex for migrations\u003c\/li\u003e\n\u003cli\u003eThesis: strong cash generator long-term\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-Stars-Star-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-growth plays: biologics, endoscopy, imaging, semiconductors, LTO storage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eHigh-growth Stars: biologics CDMO (double-digit CAGR 2024), endoscopy (~+5% procedures YoY into 2024), diagnostic imaging\/PACS (entrenched hospital share), advanced-node materials (aligned to TSMC 2024 capex USD 32–36bn), and LTO cold storage (IDC 175 ZB by 2025, LTO‑9 18TB). Continue investment to defend share, expand capacity, and convert install base to recurring revenue.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003e2024 metric\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003eAction\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eBiologics CDMO\u003c\/td\u003e\n\u003ctd\u003eDouble‑digit CAGR\u003c\/td\u003e\n\u003ctd\u003eCapacity builds\u003c\/td\u003e\n\u003ctd\u003eInvest\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEndoscopy\u003c\/td\u003e\n\u003ctd\u003e+5% volumes\u003c\/td\u003e\n\u003ctd\u003eRecurring consumables\u003c\/td\u003e\n\u003ctd\u003eScale sales\/R\u0026amp;D\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eImaging\/PACS\u003c\/td\u003e\n\u003ctd\u003eHigh share\u003c\/td\u003e\n\u003ctd\u003eSticky accounts\u003c\/td\u003e\n\u003ctd\u003eFund R\u0026amp;D\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSemiconductor\u003c\/td\u003e\n\u003ctd\u003eTSMC capex 32–36bn\u003c\/td\u003e\n\u003ctd\u003eEUV\/CMP positions\u003c\/td\u003e\n\u003ctd\u003eDefend tech\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLTO Cold Storage\u003c\/td\u003e\n\u003ctd\u003eIDC 175ZB by 2025\u003c\/td\u003e\n\u003ctd\u003eLTO‑9 18TB\u003c\/td\u003e\n\u003ctd\u003eExpand capacity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOverview of Fujifilm’s products across BCG quadrants with strategic buy\/hold\/sell guidance and trend-driven risks and opportunities\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eOne-page BCG matrix for Fujifilm Holdings, clarifying portfolio focus and easing executive decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eash Cows\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eINSTAX instant cameras and film\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eINSTAX instant cameras and film deliver mass-market reach and strong retail penetration; Instax holds over 90% of the global instant camera market and consumables carry very high margins, printing reliable cash. Category growth has cooled to low-single digits, but share is high and sticky, requiring minimal promo beyond seasonal pushes. Milk efficiently and reinvest selectively in line extensions and premium SKUs to sustain margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGraphic arts \u0026amp; offset printing plates\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMature market but Fujifilm's graphic arts \u0026amp; offset printing plates remain cash cows, supported by long-term contracts and high client retention that sustain steady cash generation. Good margins stem from scale and proprietary process know-how, with incremental capex focused on yield improvements and lower unit costs. Priority is maintaining service levels, defending key accounts and avoiding over-investment to preserve ROI.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBusiness Innovation (office MFPs \u0026amp; services)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOffice print volumes are essentially flat and global MFP shipments fell about 5% in 2023 (IDC), yet Fujifilm’s Business Innovation maintains a substantial regional share, contributing roughly 8% of Fujifilm Holdings’ FY2024 revenue. Recurring service contracts and consumables sustain steady cash flow and high margins. Management prioritizes productivity gains and cost control over capex-heavy pushes. Harvesting earnings funds higher-growth R\u0026amp;D and healthcare\/digital bets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMirrorless X‑Series cameras \u0026amp; lenses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAs of 2024 Fujifilm X‑Series sits in Cash Cows: imaging hardware is a mature market but X‑Series commands a loyal, profitable niche with repeat, high‑margin lens and body purchases that sustain steady cashflow. Marketing can remain targeted; community word‑of‑mouth reduces CAC. Roadmap should prioritize margin over volume.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\u003c\/ul\u003e\n\u003cli\u003eHigh margins from lenses and bodies\u003c\/li\u003e\n\u003cli\u003eStrong brand loyalty and community advocacy\u003c\/li\u003e\n\u003cli\u003eTargeted marketing keeps costs low\u003c\/li\u003e\n\u003cli\u003eMaintain roadmap, avoid chasing share at margin expense\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical service contracts \u0026amp; consumables\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMedical service contracts and consumables are classic cash cows: a large installed base across hospitals and clinics delivers predictable renewals and solid margins; growth is modest in 2024 but share remains entrenched. Efficiency upgrades convert directly to cash, so keeping uptime and customer success keeps churn near zero.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLarge installed base — entrenched in hospitals\/clinics\u003c\/li\u003e\n\u003cli\u003ePredictable renewals — recurring revenue in 2024\u003c\/li\u003e\n\u003cli\u003eSolid margins — upgrades flow to cash\u003c\/li\u003e\n\u003cli\u003eLow churn — uptime\/customer success critical\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/BCG-Content-CashCows-Icon-Dollar-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInstant cameras: \u003cstrong\u003e\u0026gt;90%\u003c\/strong\u003e share, consumables fuel high margins\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eInstax \u0026gt;90% global instant camera share; high-margin consumables sustain cash. Graphic arts plates and medical services deliver steady renewals and margins; Business Innovation contributed ~8% of FY2024 revenue despite flat office print volumes (MFP shipments down ~5% in 2023, IDC). X‑Series is a loyal, profitable niche—prefer margin preservation over share chasing.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003e2024 datapoint\u003c\/th\u003e\n\u003cth\u003eNotes\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eInstax\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;90% market share\u003c\/td\u003e\n\u003ctd\u003eHigh consumable margins\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBusiness Innovation\u003c\/td\u003e\n\u003ctd\u003e~8% FY2024 revenue\u003c\/td\u003e\n\u003ctd\u003eRecurring services\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical\u003c\/td\u003e\n\u003ctd\u003eLarge installed base\u003c\/td\u003e\n\u003ctd\u003ePredictable renewals\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eFujifilm Holdings BCG Matrix\u003c\/h2\u003e\n\u003cp\u003eThe file you're previewing is the exact Fujifilm Holdings BCG Matrix report you'll receive after purchase. No watermarks, no demo notes—just a fully formatted, analysis-ready document crafted for strategic clarity. It arrives immediately and is ready to edit, print, or present to stakeholders. No surprises—what you see is what you get.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56163813753209,"sku":"fujifilm-bcg-matrix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/fujifilm-bcg-matrix.png?v=1762722996","url":"https:\/\/portersfiveforce.com\/products\/fujifilm-bcg-matrix","provider":"Porter's Five Forces","version":"1.0","type":"link"}